Myovant Sciences - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsMyovant Sciences

Myovant Sciences(MYOV)

Roivant Sciences is a healthcare company focused on applying technology to drug development. Roivant builds subsidiary biotech and healthcare technology companies. Roivant was founded by Vivek Ramaswamy in 2014.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Quarterly

Annual

Annual

Projections

*Quarterly sales USD (in millions)

Plot placeholder

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Myfembree	Relugolix, Estradiol, Norethindrone	2021-05-26	2024-2038	Prostatic neoplasms , Breast neoplasms , Menorrhagia , Acne vulgaris , Leiomyoma , Endometriosis , Primary ovarian insufficiency , Endometrial hyperplasia , Hot flashes , Hypogonadism , Premature menopause
Orgovyx	Relugolix	2020-12-18	2024-2038	Prostatic neoplasms , Breast neoplasms , Menorrhagia , Acne vulgaris , Leiomyoma , Endometriosis , Primary ovarian insufficiency , Endometrial hyperplasia , Hot flashes , Hypogonadism , Premature menopause

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

hematologic neoplasms

,

,

,

healthy volunteers/patients

,

uterine hemorrhage

,

,

,

,

,

Estradiol benzoate

,

healthy volunteers/patients

,

,

,

,

,

,

,

Estradiol valerate

,

Aglatimagene besadenovec

lower urinary tract symptoms

,

prostatic neoplasms

,

prostatic hyperplasia

,

,

neuroendocrine tumors

,

pituitary neoplasms

,

pituitary acth hypersecretion

,

pituitary diseases

,

acth-secreting pituitary adenoma

,

dumping syndrome

,

,

hereditary nephritis

,

myocardial infarction

,

coronary artery disease

respiratory tract infections

,

,

,

,

general anesthesia

Histone-arginine methyltransferase carm1

,

,

,

,

thrombocytopenic purpura idiopathic

,

,

photosensitivity disorders

,

,

,

precursor cell lymphoblastic leukemia-lymphoma

,

multiple myeloma

,

plasma cell neoplasms

,

rheumatoid arthritis

,

,

,

chronic hepatitis c

,

chronic hepatitis b

,

,

chronic hepatitis

,

,

,

anxiety disorders

,

,

,

,

,

,

acquired immunodeficiency syndrome

,

communicable diseases

,

,

immunologic deficiency syndromes

,

inflammatory breast neoplasms

,

atrial fibrillation

,

macular degeneration

,

,

pulmonary tuberculosis

,

,

,

thrombocytopenia

,

non-small-cell lung carcinoma

,

,

systemic lupus erythematosus

,

,

,

,

diabetes mellitus

,

multiple sclerosis

,

relapsing-remitting multiple sclerosis

,

,

coronary disease

,

coronary artery disease

,

myocardial ischemia

,

,

atherosclerosis

,

ovarian neoplasms

,

endometrial neoplasms

,

ovarian epithelial carcinoma

,

respiratory syncytial viruses

,

breast neoplasms

,

,

postmenopausal osteoporosis

,

alzheimer disease

,

personal satisfaction

,

hypersensitivity

,

dentin sensitivity

,

tension-type headache

,

,

,

prostatic hyperplasia

,

,

,

,

,

,

,

,

spinal cord injuries

,

erectile dysfunction

,

,

chronic obstructive pulmonary disease

,

,

migraine disorders

,

type 2 diabetes mellitus

,

,

prostatic neoplasms

,

,

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use